HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

Conditions

Hepatitis C | Hepatitis C Virus (HCV)

What is the purpose of this trial?

The primary purpose of the HCV-TARGET study is to establish a nationwide registry of patients undergoing treatment with antiviral therapies for chronic hepatitis C (HCV) at both academic and community practices.


Participation Guidelines

Age:
18 Years and older
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
University of North Carolina at Chapel Hill
Dates:
07/03/2014
Last Updated:
Study HIC#:
1204010018